Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;8(1):123-125.
doi: 10.1111/jdi.12600. Epub 2016 Dec 9.

New glycemic targets for patients with diabetes from the Japan Diabetes Society

Eiichi Araki  1 , Masakazu Haneda  2 , Masato Kasuga  3 , Takeshi Nishikawa  1 , Tatsuya Kondo  1 , Kohjiro Ueki  4 , Takashi Kadowaki  5
Affiliations

New glycemic targets for patients with diabetes from the Japan Diabetes Society

Eiichi Araki et al. J Diabetes Investig. 2017 Jan.

Abstract

In the 'Evidence-based Practice Guideline for the Treatment for Diabetes in Japan 2013', a new concept of the glycemic control in patients with diabetes in Japan has been declared from the Japan Diabetes Society. The main objective value of HbA1c was set to <7% from the perspective of preventing microvascular complications. On the other hand, the objective in cases where objectives can be attained by appropriate dietary or exercise therapy, or during pharmacotherapy without the occurrence of side effects such as hypoglycemia was set to <6%, and the objective in cases where intensification of treatment was considered difficult due to side effects such as hypoglycemia or for other reasons was set to <8%. Treatment objectives should be established individually, in consideration of age, duration of disease, organ damage, risk of hypoglycemia, support structure, and etc.

Keywords: Diabetes mellitus; HbA1c; Kumamoto Declaration 2013.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Glycemic control objectives. The main objective value of HbA1c was set to <7% from the perspective of preventing complications. The objective when aiming to normal glycemia was set to <6%, and the objective when intensification of therapy considered difficult was set to <8%.
See this image and copyright information in PMC

References

    1. Ohkubo Y, Kishikawa H, Araki E, et al Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non‐insulin‐dependent diabetes mellitus:a randomized prospective 6‐year study. Diabetes Res Clin Pract 1995; 28: 103–117. - PubMed
    1. Tominaga M, Eguchi H, Manaka H, et al Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose:the Funagata Diabetes Study. Diabetes Care 1999; 22: 920–924. - PubMed
    1. Holman RR, Paul SK, Bethel MA, et al 10‐year follow‐up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577–1589. - PubMed
    1. Nathan DM, Cleary PA, Backlund JY, et al Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643–2653. - PMC - PubMed
    1. Gerstein HC, Miller ME, Byington RP, et al Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–2559. - PMC - PubMed

MeSH terms